Marex Group, PLC. Class Action Lawsuit

Robbins LLP is Investigating Allegations that Marex Group PLC (MRX) Mislead Investors Regarding its Revenue Projections  

Robbins LLP informs stockholders that a class action was filed on behalf of all persons and entities that sold short Marex Group PLC (NASDAQ: MRX) securities between August 14, 2024 and August 5, 2025.  Marex is a U.K.-based diversified global financial services platform.

The Allegations:

According to the complaint, defendants failed to inform investors that it improperly inflated its cash flow and the revenues, assets, and profits of its Market Making segment through off-book intercompany transaction.  As a result of this misconduct, class members have suffered significant loss and damages.


What Now: You may be eligible to participate in the class action against Marex Group PLC. Shareholders who wish to serve as lead plaintiff for the class must submit their papers to the court by December 8, 2025. The lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation.  You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses. 

Send us a message for more information.

Additional Alerts for Shareholders

Dexcom, Inc. Class Action Lawsuit

Robbins LLP is Investigating Allegations that Dexcom, Inc. (DXCM) Mislead Investors Regarding the Safety of its Continuous Glucose Monitoring Systems   Robbins LLP informs stockholders that

Read More »
Free!
Skip to content